GLP-1 Cost and Insurance: What You'll Actually Pay
Branded list prices, why compounded GLP-1 is so much cheaper, how insurance coverage really works for obesity vs diabetes, and ways to lower the bill.
7 min read · Last reviewed 2026-09-01 by the TopGLP1 Editorial Team
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
Key takeaways
- Branded GLP-1 lists around $1,000–$1,350/month without insurance.
- Compounded versions run roughly $100–$300/month cash.
- Insurance often covers GLP-1 for diabetes but excludes it for obesity.
- Manufacturer savings cards and cash-price vials can cut branded costs.
The three ways to pay
GLP-1 pricing confuses people because there are really three separate markets: branded drugs through insurance, branded drugs paid in cash, and compounded drugs through telehealth. What you pay depends entirely on which lane you're in.
Branded, list price
Without any discount, Wegovy and Zepbound list in the ballpark of $1,000–$1,350 a month. Almost nobody should pay full list — manufacturers offer cash programs and savings cards, and lower-priced single-dose vials have appeared for some strengths — but the sticker explains why cost is the number-one reason people look for alternatives.
Compounded, cash
Compounded semaglutide and tirzepatide through telehealth typically run $100–$300 a month, sometimes less for semaglutide. This is the same active molecule prepared by a compounding pharmacy rather than the branded finished product. It's the reason the telehealth GLP-1 boom exists — but the trade-off is that compounded products aren't individually FDA-reviewed, so the pharmacy's legitimacy matters, and availability shifts with FDA shortage rules.
How insurance really behaves
The single most important quirk: many plans cover GLP-1 drugs for type 2 diabetes (Ozempic, Mounjaro) but specifically exclude them for weight loss (Wegovy, Zepbound). Even when obesity coverage exists, prior authorization and step-therapy requirements are common. Check your plan's formulary for the exact brand and indication before assuming anything.
Ways to lower the bill
- Manufacturer savings cards for eligible, commercially insured patients
- Manufacturer cash/self-pay programs for those without coverage
- Lower-cost single-dose vials where offered
- Compounded GLP-1 through a vetted, licensed telehealth clinic
- HSA/FSA dollars, which usually apply to prescribed treatment
- Asking your clinician to document a covered indication if you medically qualify
Sources & references
Clinical figures on this page trace to peer-reviewed trials and official regulators. We link the primary record so you can verify it yourself.
- 1.U.S. Food & Drug Administration. FDA Clarifies Policies for Compounders as National GLP-1 Supply Begins to Stabilize.RegulatoryU.S. Food & Drug Administration
- 2.U.S. Food & Drug Administration. FDA Drug Shortages database.RegulatoryU.S. Food & Drug Administration
- 3.U.S. Food & Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.RegulatoryU.S. Food & Drug Administration